| | Call Details | ATS Medical Earnings Conference Call (Q2 2009) Mon,
Aug 3, 2009, 5:00 pm Eastern
| | About ATS Medical
(NasdaqGM:ATSI) | Other Calls | | ATS Medical, Inc. engages in the development, manufacture, and marketing of medical devices for the treatment of structural heart diseases. It offers prosthetic heart valves, such as ATS Open Pivot Heart Valve, a mechanical heart valve, as well as ATS 3F Aortic Bioprosthesis, a biological replacement aortic heart valve; and heart valve repair products, such as ATS Simulus Flexible annuloplasty repair rings and bands, ATS Simulus Semi-Rigid Annuloplasty Ring, and ATS Simulus Adjustable repair rings. The company also markets and sells surgical cryoablation products for the treatment of cardiac arrhythmias, including the ATS CryoMaze Surgical Ablation Probe, the ATS CryoMaze and FrostByte Surgical Ablation Clamps, and the ATS CryoMaze Surgical Ablation Consoles. In addition, it is developing minimally invasive and off-pump aortic valve concepts. The company markets and sells its products through direct sales representatives and agents in the United States, France, Germany, the United Kingdom, Belgium, the Netherlands, and Switzerland; and sells through an independent distributor network to cardiac surgeons throughout the world. ATS Medical, Inc. was founded in 1987 and is based in Minneapolis, Minnesota. |
| More
Info:
Quote
|
Chart
|
News
|
Profile
|
Reports
|
Research
|
SEC
|
Msgs
|
Insider
|
Financials
|
Analyst Ratings |
|